Safety and immunogenicity of inactivated poliovirus vaccine when given with measles–rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia
Clarke, Ed, Dr, Saidu, Yauba, MD, Adetifa, Jane U, MD, Adigweme, Ikechukwu, MBBS, Hydara, Mariama Badjie, MBBS, Bashorun, Adedapo O, MBBS, Moneke-Anyanwoke, Ngozi, MBBS, Umesi, Ama, MBBS, Roberts, Elishia, BSc, Cham, Pa Modou, BSc, Okoye, Michael E, MBBS, Brown, Kevin E, MBBS, Niedrig, Matthias, Prof, Chowdhury, Panchali Roy, MSc, Clemens, Ralf, MD, Bandyopadhyay, Ananda S, MBBS, Mueller, Jenny, MD, Jeffries, David J, PhD, Kampmann, Beate, Prof
Published in The Lancet global health (01.08.2016)
Published in The Lancet global health (01.08.2016)
Get full text
Journal Article
Tolerability, safety, and immunogenicity of the novel oral polio vaccine type 2 in children aged 6 weeks to 59 months in an outbreak response campaign in The Gambia: an observational cohort study
Bashorun, Adedapo O, Kotei, Larry, Jawla, Ousubie, Jallow, Abdoulie F, Saidy, Aisha J, Kinteh, Ma-Ansu, Kujabi, Arafang, Jobarteh, Tijan, Kanu, Francis John, Donkor, Simon A, Ezeani, Esu, Fofana, Sidat, Njie, Mbye, Ceesay, Lamin, Jafri, Basit, Williams, Amanda, Jeffries, David, Kotanmi, Brezesky, Mainou, Bernardo A, Ooko, Michael, Clarke, Ed
Published in The Lancet infectious diseases (01.04.2024)
Published in The Lancet infectious diseases (01.04.2024)
Get full text
Journal Article
Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia—Results of a phase 1/2 randomized, double-blinded, controlled trial
Clarke, Ed, Bashorun, Adedapo O., Okoye, Michael, Umesi, Ama, Badjie Hydara, Mariama, Adigweme, Ikechukwu, Dhere, Rajeev, Sethna, Vistasp, Kampmann, Beate, Goldblatt, David, Tate, Andi, Weiner, Debra H, Flores, Jorge, Alderson, Mark R., Lamola, Steve
Published in Vaccine (10.01.2020)
Published in Vaccine (10.01.2020)
Get full text
Journal Article
Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The Gambia
Bashorun, Adedapo O, Badjie Hydara, Mariama, Adigweme, Ikechukwu, Umesi, Ama, Danso, Baba, Johnson, Njilan, Sambou, Ngally Aboubacarr, Fofana, Sidat, Kanu, Francis J, Jeyaseelan, Visalakshi, Verma, Harish, Weldon, William C, Oberste, M Steven, Sutter, Roland W, Jeffries, David, Wathuo, Miriam, Mach, Ondrej, Clarke, Ed
Published in The Lancet global health (01.02.2022)
Published in The Lancet global health (01.02.2022)
Get full text
Journal Article
The Immunogenicity of Fractional Intradermal Doses of the Inactivated Poliovirus Vaccine Is Associated With the Size of the Intradermal Fluid Bleb
Bibby, Jack, Saidu, Yauba, Umesi, Ama, Moneke-Anyanwoke, Ngozi, Bashorun, Adedapo O., Hydara, Mariama Badjie, Adigweme, Ikechukwu, Adetifa, Jane U., Okoye, Michael, Roberts, Elishia, Clemens, Ralf, Bandyopadhyay, Ananda S., Muhammad, Abdul K., Mulwa, Sarah, Royals, Michael, Jarrahian, Courtney, Jeffries, David, Kampmann, Beate, Clarke, Ed
Published in Clinical infectious diseases (01.09.2017)
Published in Clinical infectious diseases (01.09.2017)
Get full text
Journal Article